glofitamab
roche
['glofitamab', 'lymsm', 'lymphoma']
bispecific antibodies: another win for t-cells! #lymsm #ash22 #glofitamab 
Clinical haematologist at Peter MacCallum Cancer Centre in Melbourne. Aggressive Lymphoma Lead. MDS/AML/myeloma.Early phase trials. Views are my own.